Rose Health is a remote patient monitoring platform that helps healthcare providers connect with patients and monitor their mental health conditions. For healthcare providers, it offers a HIPAA-compliant telepsychiatry platform for appointment scheduling, collecting patient data, and dashboards to view patient information. In dealing with patients, Rose Health leverages artificial intelligence and natural language processing to assess a user’s mood and identify early warning signs of depression and other mental disorders. Rose is also one of the privileged companies to be admitted to the Johns Hopkins’ Hexcite Accelerator program and the Halcyon House incubator program.
Rose is testing a youth platform focused on delivering mental healthcare for adolescents. It plans to run a six-month pilot with Intermountain Healthcare in Q2 2022. Given its current contracts and pipeline of services, the company expects revenue to reach USD 2.3 million in 2022
In February 2022, the firm announced it is raising USD 7.5 million in a Series A funding round, with USD 3.5 million already committed. The round is set to close at the end of March 2022. The funds have been earmarked to expand its workforce by adding 34 new positions throughout 2022, as well as to support its product development and geographic expansion plans. Additionally, Rose has planned to hire licensed clinical social workers to create an at-home monitoring team for individuals using its platform.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.